Cleared Special

K031465 - MODEL 2100 PULSE OXIMETER

K031465 is an FDA 510(k) clearance for MODEL 2100 PULSE OXIMETER, manufactured by Dolphin Medical, Inc.. The device is a Class 2 Anesthesiology device with product code DQA cleared through the Special 510(k) pathway after a 155-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2003
Decision
155d
Days
Class 2
Risk

K031465 is an FDA 510(k) clearance for the MODEL 2100 PULSE OXIMETER. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Dolphin Medical, Inc. (Tampa, US). The FDA issued a Cleared decision on October 10, 2003 after a review of 155 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Dolphin Medical, Inc. devices

FDA 510(k) Submission Details - K031465

510(k) Number K031465 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 08, 2003
Decision Date October 10, 2003
Days to Decision 155 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
15d slower than avg
Panel avg: 140d · This submission: 155d
Pathway characteristics
Modification to existing cleared device.

DQA Device Classification - Class 2, Special Controls

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 478
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K031465.
SPO2.COM OXIMETRY SENSORS, MULTIPLE MODELS
K033298 · Masimo Corp. · Dec 2003
DRAEGER MICRO2+ AND MASIMO MINISAT
K032537 · Draeger Medical Systems, Inc. · Nov 2003
MODEL 3100 WRISTOX PULSE OXIMETER
K030668 · Nonin Medical, Inc. · Oct 2003
MODEL 9600, AVANT PULSE OXIMETER
K023044 · Nonin Medical, Inc. · Jul 2003
PICOSAT II SPO2 PULSE OXIMETRY MODULE
K030973 · Philips Medical Systems · Jul 2003
SIEMENS MICRO2+ WITH VAI SOFTWARE
K030640 · Siemens Medical Solutions USA, Inc. · Jun 2003